Plasma levels of leptine and growth hormone after auricular and body electro acupuncture combine with low calorie diet for weight reduction in patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201107267117N1

Enrollment

250

Registered

2011-12-04

Start date

2010-09-30

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity and overweight. All neoplasms, whether functionally active or not, are classified in Chapter II. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used, if desired, as additional codes to indicate either functional activity by neoplasms and ect

Interventions

Intervention 1: The first group consist of 50 over weight and obese subjects with low-calorie diet. Intervention 2: The second group consist of 50 over weight and obese subjects with low-calorie diet

Treatment - Drugs

Placebo

The first group consist of 50 over weight and obese subjects with low-calorie diet

The second group consist of 50 over weight and obese subjects with low-calorie diet plus body electro acupuncture

The third group consist of 50 over weight and obese subjects with low-calorie diet plus sham body electro acupuncture

The fourth group consist of 50 over weight and obese subjects with low-calorie diet plus auricular acupuncture

The fifth group consist of 50 over weight and obese subjects with low-calorie diet plus sham auricular acupuncture

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: obese men and women; age between 18 to 50 without any history of illness. Exclusion criteria: Diabetes; sever hypertension; cardiac disease; endocrine abnormalities and women who were in gestation and lactation periods.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Weight and BMI. Timepoint: 1/5 months and 3 months after biging the study. Method of measurement: Body composition analyzer BC_418 (TANITA).;Waist, hips, abdomen, ankles circumstance. Timepoint: 1/5 months and 3 months after biging the study. Method of measurement: meter.;Blood pressure. Timepoint: 1/5 months and 3 months after bigining the study. Method of measurement: Mercury pressure indicator.	—

Measure

Time frame

Weight and BMI. Timepoint: 1/5 months and 3 months after biging the study. Method of measurement: Body composition analyzer BC_418 (TANITA).;Waist, hips, abdomen, ankles circumstance. Timepoint: 1/5 months and 3 months after biging the study. Method of measurement: meter.;Blood pressure. Timepoint: 1/5 months and 3 months after bigining the study. Method of measurement: Mercury pressure indicator.

—

Secondary

Measure	Time frame
Leptin hormone and grouth hormone. Timepoint: 1.5 month. Method of measurement: ELISA method.;Biochemical parameters. Timepoint: 1.5 month. Method of measurement: Radioimmunoassay method.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Majid Ghayour Mobarhan

Mashhad University of Medical Scinces

GhayourM@mums.ac.ir; mahsasaraa@gmail.com+98 915 517 1478

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026